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Introduction
Stroke is the second leading cause of death world
wide1 and the third leading cause of death in the developed
world. Stroke causes over 5.5 million deaths globally every
year2, two thirds of which occur in the developing world.3
Moreover, stroke leads to higher disability adjusted life
years (DALY) impact in developing countries compared to
developed countries, making it a major public health issue.4
Cardioembolic etiology has been reported to comprise 15%
to 30% of ischaemic strokes5,6 in developed countries.
Atrial fibrillation accounts for more than 50% of
cardioembolic strokes.7 Other cardiac structural and
functional abnormalities that have been associated with
cardioembolic stroke are left atrial dilatation, poor left
ventricularsystolic function, valvular heart diseases, cardiac
tumours, patent foramen ovale and atrial septal defect.8-10
Echocardiography is performed to identify the
cardiogenic source of embolus and has been recommended
as a routine test in stroke workup.10 However the cost
effectiveness of echocardiography in secondary
prevention of stroke has generated controversy. Some
investigators have recommended echocardiographic
evaluation of all stroke patients.11 Others are suggesting
echocardiography based on specific indications.12 The
purpose of our study was to assess the utility of
transthoracic echocardiography as part of stroke workup.
In the developing world cost of evaluation of stroke
patients is a major issue and access to diagnostic
modalities is limited requiring prioritization.
Methods
Aga Khan University Hospital is a JCIA (Joint
Commission International Accredition) accredited tertiary
care hospital in Karachi, Pakistan. Stroke care is delivered
through a 24-hour on-call neurology team with a 5 bed
stroke unit and full range of ancillary services. Aga Khan
University (AKU) Stroke Data Bank enrolled all the
patients admitted with a diagnosis of stroke from August
1999 to May 2001 (22 month period). All patients over the
age of 14 years with acute stroke were prospectively
enrolled in AKU stroke databank. All patients were
evaluated by a consultant neurologist and underwent
standard stroke work up such as neuroimaging,
transthoracic echocardiography (TTE), carotid doppler
sonography and blood tests e.g. serum glucose, lipid profile,
blood urea nitrogen and serum creatinine. For the purpose
of this study,  patients with ischaemic stroke were identified
and their echocardiographic data was retrieved and
analyzed. TOAST (Trial of Org 10172 for acute stroke
treatment) criteria was used to identify findings indicating
cardioembolic stroke; prosthetic valve, left atrial dilatation
with mitral stenosis, left atrial thrombus, left ventricular
thrombus, dilated cardiomyopathy, akinetic left ventricle
segment, atrial myxoma.13
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Abstract
Objective: To assess the utility and cost effectiveness of transthoracic echocardiography (TTE) as part of stroke
workup in a developing country.
Methods: All patients over the age of 14 years with acute stroke were prospectively enrolled in Aga Khan
University stroke databank from August 1999 to May 2001 (22 month period). All patients were evaluated by a
consultant neurologist and underwent standard stroke work up such as neuroimaging, TTE, carotid doppler
sonography and blood tests e.g. serum glucose, lipid profile, blood urea nitrogen and serum creatinine. For the
purpose of this study, patients with ischemic stroke were identified and their echocardiographic data was
retrieved and analyzed. TOAST criteria was used to identify findings indicating cardioembolic stroke.
Results: Ischaemic stroke was identified in 393 (76%) patients. Of these 278 (71%) patients underwent
transthoracic echocardiography as part of stroke workup. Although 199 (73%) patients had abnormal
echocardiogram; only 43 (15.5%) had findings suggestive of possible cardioembolism as defined by the TOAST
criteria.
Conclusion: Tranthoracic echocardiography is a valid diagnostic modality for stroke workup. However there is
a need to further investigate the specific indications which can be used to prioritize patients for undergoing
echocardiography to minimize cost (JPMA 58:375;2008).
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Results
A total of 596 patients were enrolled in the study
with diagnosis of stroke. Ischaemic stroke was the
identified type in 393 (76%) patients. Mean age was 60.4
± 12.5 years and 174 (63.6%) of the patients with
ischaemic stroke were men. Of these 278 (71%) patients
underwent transthoracic echocardiography as part of
stroke workup. Although 199 (73%) patients had
abnormal echocardiogram (Table 1); only 43 (15.5%) had
findings suggestive of possible cardioembolism as
defined by the TOAST criteria13 (Table 2).
Discussion
Transthoracic echocardiography is part of the routine
workup of cardiac source of embolus in stroke patients in
many centers across the world.14,15 It is a non-invasive
procedure with a sensitivity of 86% to 95% and a specificity
of 86% to 95% for detecting left ventricular thrombi.16-18
However, there is an ongoing debate regarding the cost
effectiveness of this diagnostic tool. A recent hospital-based
study from Canada reports that transthoracic
echocardiography has a low yield, diagnosing only 4% of
ischaemic stroke patients with abnormalilties suggesting
cardioembolic etiology.19 In contrast, another single centre
study from Portugal revealed 37.2% of ischaemic stroke
patients with Transthoracic echocardiography abnormalities
suggestive cardioembolic etiology and the authors
recommended the use of echocardiography as a routine
procedure in all stroke patients.11 Our study found 16%
patients with TTE abnormalities consistent with
cardioembolic origin suggesting a difference between our
study population and those mentioned earlier.
In order to make any recommendations regarding the
routine use of echocardiography for stroke patients we
should keep in view the prevalent ischaemic stroke subtype,
cost involved, average income and the accessibility of
patients to these diagnostic modalities in a developing
country.
Earlier study published by our centre showed
lacunar stroke (42.7%) as the most common subtype of
ischaemic stroke while large artery atherosclerosis
accounted for 26.9% of ischaemic strokes.20 In contrast to
cardioembolic stroke incidence of 15% to 30% in developed
countries5,6, our study population had a lower number of
patients with cardioembolic stroke (6.1%).20 This high
frequency of lacunar infarcts is due to high prevalence of
hypertension (66.2%) and diabetes (41.5%) in our study
population which are the strongest risk factors for lacunar
infarction.21 Our high prevalence of hypertension is
comparable to other south-east Asian countries.22 Other
studies have also demonstrated a higher frequency of
lacunar infarctions in South East Asian populations as
compared to Caucasian populations23 indicating a
difference in stroke etiologies in different populations.  
A recent analysis done at our centre showed average
cost of stroke management to be 70,714 rupees (1179 U
dollars)22 with transthoracic echocardiography accounting
to about 10% of this cost. This is expensive in a country
where the gross national income (GNI) per capita of $
690.23
Tertiary health care facilities are limited in our
country. It is important to prioritize patients according to
their need for diagnostic workup so that cost of stroke
management can be decreased without compromising the
quality of care. Recently Douen et al19 showed that
detection of echocardiographic abnormalities did not
change therapy in these patients. However, the mortality
and morbidity associated with stroke as described earlier,
demands for secondary prevention treatment guided by
Table 1. Echocardiographic Findings (n = 199)*.
Findings No (%)
Left ventricular segmental wall motion abnormalities with MI
Mild left ventricular systolic dysfunction
Moderate ventricular systolic dysfunction
Severe LV dysfunction
Left ventricle thrombus
Left ventricular dilatation
Right ventricular dilatation
Biventricular dilatation
Right atrial enlargement 
Left atrial enlargement   
Mitral stenosis 
Left atrial enlargement with Mitral Stenosis 
Left ventricular Hypertrophy with diastolic dysfunction 
Valve prosthesis 
1 (7.6)
22 (7.6)
17 (6.1)
15 (5.4)
4 (1.5)
5 (1.8)
1 (0.36)
1 (0.36)
2 (0.72)
15 (5.4)
8 (2.9)
5 (1.8)
159 (57.1)
3 (1.0)
*Since some patients had more than one significant finding so the cumulative percentage of
abnormal findings is greater than the number of patients who had significant findings on
echocardiogram.
Table 2.  Echocardiography Findings consistent with TOAST criteria
for possible cardioembolism (n = 43)*.
Findings No (%)
Left ventricular segmental wall motion abnormalities with MI
Severe Left Ventricle Systolic Dysfunction 
Left Ventricle Thrombus 
Left Ventricle Dilatation 
Left Atrial Dilatation with Mitral stenosis 
Valve Prosthesis 
*Since some patients had more than one significant finding so the cumulative percentage of
abnormal findings is greater than the number of patients who had 
significant findings on echocardiogram.
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diagnostic modalities. TTE yield of 16% for secondary
prevention treatment will have a major impact in secondary
prevention of stroke. Therefore, keeping in view the yield of
echocardiographic abnormalities suggestive of
cardioembolic stroke according to TOAST criteria, low
prevalence of cardioembolic stroke in our population, high
costs involved with stroke management and
echocardiography with a low average income in our country
we recommend that transthoracic echocardiography is a
valid diagnostic modality for stroke workup. However there
is a need to further investigate the specific indications which
can be used to prioritize patients for undergoing
echocardiography to minimize cost and also to determine
whether detection of TTE abnormalities leads to any change
in treatment of these patients. This will provide us with the
actual impact of TTE in terms of cerebrovascular accidents
prevented and will decide on the inclusion of this modality
as a routine procedure for every stroke patients.
Conclusion
Transthoracic Echocariography is a useful modality
to identify the etiology of stroke in a low income setting.
However, further research is required to prioritize patients
leading to a higher yield of this effective modality. This
information will enable health policy managers to decide
about making TTE a mandatory diagnostic test in stroke
treatment protocols. 
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